Union Budget Boosts Pharma with Biopharma Shakti with Outlay of INR 10,000 Crore
Union Finance Minister Nirmala Sitharaman unveiled multiple initiatives for pharma and life sciences in budget 2026–27, including Biopharma Shakti, NIPER expansion, CDSCO strengthening and new investments, to position India as a global biopharma hub.
Union Budget 2026 | 01/02/2026 | By News Bureau | 210
Pharma Leaders Outline Key Expectations Ahead of Union Budget 2026
Pharma industry leaders are urging the government to simplify GST on essential medicines, improve ease of doing business, enable easier access to long-term capital and provide greater policy clarity, amid more, in the upcoming Union Budget 2026.
Union Budget 2026 | 28/01/2026 | By News Bureau | 332
ISCR Urges Union Budget 2026 to Focus on Boosting India's Clinical Research Ecosystem
ISCR seeks higher funding, AI-led innovation and regulatory reforms in Union Budget 2026 to boost global competitiveness and accelerate patient access to therapies.
Union Budget 2026 | 17/01/2026 | By News Bureau | 175
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy